VIVUS Extends Invitation to First Manhattan for Three of Their Nominees to Join the Board of Directors
July 13, 2013 23:32 ET
|
VIVUS, Inc.
VIVUS Offers a Compromise to End the Proxy Contest
VIVUS Stockholders Encouraged to Vote the GOLD Card in Favor of VIVUS Nominees and to
Notify FMC of Your Support for This Compromise
MOUNTAIN...
VIVUS Reminds Stockholders to Vote the GOLD Proxy Card by Telephone or Internet Today
July 11, 2013 07:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., July 11, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company"), a pharmaceutical company commercializing and developing innovative, next-generation therapies to...
Strong Support for VIVUS's Board and Management Team Among Influential Financial Analysts
July 10, 2013 07:00 ET
|
VIVUS, Inc.
VIVUS's Board and Management Team Are Executing on the Right Strategy to Maximize Stockholder Value
VIVUS's Board Urges Stockholders to Vote FOR the Board's Nominees on the GOLD Proxy Card...
VIVUS Board and Management Team Successfully Executing Plan to Unlock the Full Potential of Qsymia
July 09, 2013 07:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., July 9, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company"), a pharmaceutical company commercializing and developing innovative, next-generation therapies to...
VIVUS Announces Avanafil Partnership With Menarini
July 09, 2013 03:00 ET
|
VIVUS, Inc.
Menarini to Launch and Market SPEDRA in 40 Countries in Europe and Abroad
VIVUS to Receive Upfront Payment Plus Milestones and Royalties Over the Term of the Agreement
MOUNTAIN VIEW, Calif.,...
Two Leading Proxy Advisory Firms Reject FMC's Attempt to Take Control of VIVUS's Board
July 05, 2013 07:00 ET
|
VIVUS, Inc.
ISS Supports Majority of VIVUS's Directors Retaining Control
Glass Lewis Recommends Stockholders Do Not Vote for Any FMC Nominees
Glass Lewis Notes VIVUS is "Making Encouraging Progress to...
VIVUS to Present at Upcoming Investor Conference
July 02, 2013 07:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., July 2, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at the following investment...
VIVUS Mails Letter to Stockholders
July 02, 2013 07:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., July 2, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company"), a pharmaceutical company commercializing and developing innovative, next-generation therapies to...
VIVUS Announces Initial Availability of Qsymia(R) Through Certified Retail Pharmacies
July 01, 2013 07:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., July 1, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the initial availability of Qsymia® (phentermine and topiramate extended-release) capsules CIV in...
VIVUS Clarifies Additional Misstatements by First Manhattan Co.
June 28, 2013 07:00 ET
|
VIVUS, Inc.
MOUNTAIN VIEW, Calif., June 28, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company"), a pharmaceutical company commercializing and developing innovative, next-generation therapies to...